Panel discussion and summary - Who should receive the Wearable Cardioverter Defibrillator (WCD)? Evidence and risk stratification for prevention of sudden cardiac death.

17 March 2019 (00:00 - 00:00)
Organised by:

ESC 365 is supported by

ESC 365 is supported by